.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
McKinsey
Cantor Fitzgerald
Chubb
Deloitte
Colorcon
Boehringer Ingelheim
Citi
Moodys
Accenture

Generated: July 20, 2017

DrugPatentWatch Database Preview

Metaraminol bitartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaraminol bitartrate and what is the scope of metaraminol bitartrate patent protection?

Metaraminol bitartrate
is the generic ingredient in two branded drugs marketed by Merck, Gd Searle Llc, Fresenius Kabi Usa, Abraxis Pharm, and Elkins Sinn, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: metaraminol bitartrate

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Bulk Api Vendors: see list31
Clinical Trials: see list46
Patent Applications: see list491
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metaraminol bitartrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION080722-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Elkins Sinn
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION083363-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Merck
ARAMINE
metaraminol bitartrate
INJECTABLE;INJECTION009509-002Dec 22, 1987DISCNYesNo► Subscribe► Subscribe
Abraxis Pharm
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION080431-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Gd Searle Llc
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION086418-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Argus Health
Express Scripts
Covington
AstraZeneca
Daiichi Sankyo
Moodys
Accenture
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot